- Home
- J&J Innovative Medicine Research & Development
J&J Innovative Medicine Research & Development
Alzheimer’s disease: Why one company refuses to give up the search for a cure
It’s the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
Cracking the genetic code: Why gene sequencing may hold the key to intercepting diseases before they start
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
Have IBD? Read about the next frontier in disease research that taps into the microbiome
There are trillions of microorganisms living in your gut—and they might just be the key to helping treat diseases like Crohn’s and ulcerative colitis. Meet a researcher who spends her days exploring this microscopic world.
4 questions for a scientist determined to find a functional cure for hepatitis B
Despite being one of the oldest viruses known to infect man, there’s been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
5 things to know about the 2018 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.
New Year, new vision: Meet a woman determined to find a cure for Type 2 diabetes
Hundreds of millions of people worldwide have type 2 diabetes. And Chiara Magnone has her sights set on changing what it means to live with the condition, as well as how common complications like chronic kidney disease are treated.
Johnson & Johnson’s new Chief Financial Officer answers 7 popular investor questions
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company’s fiscal future.
In search of the next great female thinkers: Why Johnson & Johnson is on a STEM2D mission
The company just awarded six promising female researchers $150,000 each through its new Scholars Award program—and that’s not the only way it’s helping women working in the sciences.
“Ebola: The fight continues four years after the worst outbreak in history
Macaya Douoguih volunteered to lead an accelerated clinical program for a new investigational Ebola vaccine at the height of the 2014 epidemic in West Africa. She reflects on her experiences—and why her work must continue today.